Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder
Top Cited Papers
Open Access
- 1 January 2025
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 82 (1) , 94-98
Abstract
According to the World Health Organization, harmful use of alcohol is accountable for 5.1% of the global burden of disease.1 Psychosocial treatments are the cornerstone of alcohol use disorder (AUD) treatment, but pharmacological treatments are also beneficial, although underused.2,3Keywords
This publication has 13 references indexed in Scilit:
- The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmissionJCI Insight, 2023
- Semaglutide reduces alcohol intake and relapse-like drinking in male and female ratsEBioMedicine, 2023
- Use of GLP‐1 receptor agonists and subsequent risk of alcohol‐related events. A nationwide register‐based cohort and self‐controlled case series studyBasic & Clinical Pharmacology & Toxicology, 2022
- The role of glucagon‐like peptide 1 (GLP‐1) in addictive disordersBritish Journal of Pharmacology, 2021
- Real‐world effectiveness of pharmacological treatments of alcohol use disorders in a Swedish nation‐wide cohort of 125 556 patientsAddiction, 2021
- Prevention, screening, and treatment for heavy drinking and alcohol use disorderThe Lancet Psychiatry, 2019
- Correction to: Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeysPsychopharmacology, 2019
- Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older personsClinical Epidemiology, 2016
- The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependenceTranslational Psychiatry, 2015
- From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)BMC Medical Informatics and Decision Making, 2015